CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Year-over-year research & development expense growth
Latest
-21.09%
↓ 249% vs avg
Percentile
P8
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
14.14%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -21.09% |
| 2024 | 7.34% |
| 2023 | -30.42% |
| 2022 | -2.23% |
| 2021 | 1.11% |
| 2020 | -14.19% |
| 2019 | 26.72% |
| 2018 | 12.56% |
| 2017 | 68.53% |
| 2016 | 93.09% |